Ke Ji Ri Bao·2026-01-08 08:30Core Insights - The article highlights the significant role of AI in early cancer detection, particularly in identifying pancreatic cancer that may be missed by doctors [1][2] Group 1: AI Technology and Impact - The DAMO PANDA AI model, developed by Alibaba's DAMO Academy, has analyzed over 180,000 CT scans at Ningbo University Affiliated People's Hospital, leading to the discovery of 24 cases of pancreatic cancer, with 14 being early-stage [1] - The AI system is capable of amplifying and capturing subtle lesions in CT images that are difficult for the human eye to detect, thereby improving early cancer detection rates, especially in opportunistic screening scenarios [2] Group 2: Collaborative Efforts and Regulatory Approval - The pancreatic cancer AI early screening project is a collaborative pilot initiative involving multiple institutions, including Ningbo University Affiliated People's Hospital, Shanghai Pancreatic Disease Research Institute, Jiaxing Second Hospital, and several community hospitals [2] - The PANDA model received "breakthrough medical device" designation from the U.S. Food and Drug Administration (FDA) in April last year, which accelerates the review process for advanced diagnostic tools to be made available to patients and healthcare providers [2]